Metalloproteinases in corneal diseases: Degradation and processing

Cornea

Volumn 31, Issue 11 SUPPL.1, 2012, Pages

  Sakimoto, Tohru ^a   Sawa, Mitsuru ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

a disintegrin and metalloproteinase; cornea; matrix metalloproteinases

Indexed keywords

ADAM PROTEIN; GELATINASE A; GELATINASE B; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MATRIX METALLOPROTEINASE; MESSENGER RNA; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR RECEPTOR 1;

CELL CULTURE; COLLAGEN DISEASE; CONFERENCE PAPER; CORNEA DISEASE; CORNEA EPITHELIUM; CORNEA EROSION; CORNEA STROMA; CORNEA ULCER; CYTOKINE PRODUCTION; ENZYME DEGRADATION; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; LACRIMAL FLUID; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RECURRENT DISEASE; RNA SPLICING; SIGNAL TRANSDUCTION; UPREGULATION;

CORNEAL DISEASES; HUMANS; MATRIX METALLOPROTEINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; TEARS;

EID: 84867385107     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318269ccd0     Document Type: Conference Paper

References (25)

1. Dawson DG, Ubels JL, Edelhauser HF. Cornea and sclera. In: Levin LA, ed. Adler's Physiology of the Eye. 11th ed. Amsterdam, The Netherlands: Elsevier; 2011:71-181.
2. Sorokin L. The impact of the extracellular matrix on inflammation. Nat Rev Immunol. 2010;10:712-723.
3. Blobel CP. ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol. 2005;6:32-43.
4. Huovila AP, Turner AJ, Pelto-Huikko M, et al. Shedding light on ADAM metalloproteinases. Trends Biochem Sci. 2005;30:413-422.
5. Matsubara M, Zieske JD, Fini ME. Mechanism of basement membrane dissolution preceding corneal ulceration. Invest Ophthalmol Vis Sci. 1991;32:3221-3237.
6. Fini ME, Parks WC, Rinehart WB, et al. Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury. Am J Pathol. 1996; 149:1287-1302.
7. Azar DT, Hahn TW, Jain S, et al. Matrix metalloproteinases are expressed during wound healing after excimer laser keratectomy. Cornea. 1996;15:18-24.
8. Sakimoto T, Shoji J, Sawa M. Active form of gelatinases in tear fluid in patients with corneal ulcer or ocular burn. Jpn J Ophthalmol. 2003;47: 423-426.
9. Sakimoto T, Shoji J, Kanno H, et al. Gelatinase expression in ocular surface disorders. Jpn J Ophthalmol. 2004;48:17-22.
10. Das S, Seitz B. Recurrent corneal erosion syndrome. Surv Ophthalmol. 2008;53:3-15.
11. Sakimoto T, Shoji J, Yamada A, et al. Upregulation of matrix metalloproteinase in tear fluid of patients with recurrent corneal erosion. Jpn J Ophthalmol. 2007;51:343-346.
12. Black RA, Rauch CT, Kozlosky CJ, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 1997;385: 729-733.
13. Sakimoto T, Yamada A, Sawa M. Release of soluble tumor necrosis factor receptor 1 from corneal epithelium by TNF-alpha-converting enzyme-dependent ectodomain shedding. Invest Ophthalmol Vis Sci. 2009;50:4618-4621.
14. Cook EB, Stahl JL, Graziano FM, et al. Regulation of the receptors for TNFalpha, TNFR1, in human conjunctival epithelial cells. Invest Ophthalmol Vis Sci. 2008;49:3992-3998.
15. Sakimoto T, Yamada A, Kanno H, et al. Upregulation of tumor necrosis factor receptor 1 and TNF-alpha converting enzyme during corneal wound healing. Jpn J Ophthalmol. 2008;52:393-398.
16. Saika S, Ikeda K, Yamanaka O, et al. Loss of tumor necrosis factor alpha potentiates transforming growth factor beta-mediated pathogenic tissue response during wound healing. Am J Pathol. 2006;168: 1848-1860.
17. Wilson SE. Role of apoptosis in wound healing in the cornea. Cornea. 2000;19(3 suppl):S7-S12.
18. Ruuls SR, Hoek RM, Ngo VN, et al. Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity. 2001;15:533-543.
19. Kishimoto T, Akira S, Taga T. Interleukin-6 and its receptor: A paradigm for cytokines. Science. 1992;258:593-597.
20. Jones SA, Horiuchi S, Topley N, et al. The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J. 2001; 15:43-58.
21. Scheller J, Ohnesorge N, Rose-John S. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol. 2006;63:321-329.
22. Sugaya S, Sakimoto T, Shoji J, et al. Regulation of soluble interleukin-6 (IL-6) receptor release from corneal epithelial cells and its role in the ocular surface. Jpn J Ophthalmol. 2011;55:277-282.
23. Chan KY, Haschke RH. Epithelial-stromal interactions: Specific stimulation of corneal epithelial cell growth in vitro by a factor(s) from cultured stromal fibroblasts. Exp Eye Res. 1983;36:231-246.
24. Gabison EE, Huet E, Baudouin C, et al. Direct epithelial-stromal interaction in corneal wound healing: Role of EMMPRIN/CD147 in MMPs induction and beyond. Prog Retin Eye Res. 2009;28:19-33.
25. Nowell MA, Richards PJ, Horiuchi S, et al. Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130. J Immunol. 2003;171:3202-3209.